Breaking News

NEW YORK, March 25 - Agencourt Bioscience on Monday said that the Duke University Medical Center has picked its Solid Phase Reversible Immobilization technology to help its cancer research.

NEW YORK, March 25 - The protein chip market is "poised for enormous growth" over the next four years, a recent industry study has found.

NEW YORK, March 25 - At the bottom of the world, a handful of very cold researchers risked freezing their pipettes off trying to understand

NEW YORK, March 25 - A bruising court ruling has set back Waters' year-end financial results and hurt its first-quarter outlook, the company has said.

MOUNTAIN VIEW, Calif., March 25 - A crowd of 400 software entrepreneurs slumped into a lecture hall here this month to learn a few secrets of biology and drug discovery.

SAN FRANCISCO, March 25 - IBM has fast-tracked the process of integrating open-source protocols into the software that runs a US Department of Energy-IBM supercomputer at Lawrence Berkeley National Laboratory here.

SAN FRANCISCO, March 25 - IBM has fast-tracked the process of integrating open-source protocols into

REDWOOD CITY, Calif., March 22 - Incyte Genomics co-founder Randy Scott and his latest creation, Genomic Health, are in stealth mode.

NEW ORLEANS, March 22 - In spite of the fact that most of the analytical chemists who hiked up and down the aisles of Pittcon 2002 here this week would be hard pressed to tell you what a proteome is, it is fair to say that proteomics made its mark on the mas

LOS ANGELES, March 22 - If there's one thing that publicly traded genomics companies may count on After Enron it is that cash is the new king.

NEW YORK, March 21 - A project to develop an integrated genetic and physical map of the maize genome is roughly halfway done.

NEW YORK, March 21 - Gene Logic said that its toxicology platform is now robust enough to predict the toxic properties of drug-compound candidates.

NEW YORK, March 21 - Fulfilling its promise, Enzo Diagnostics has filed a patent-infringement suit against Digene that seeks an injunction and monetary damages.  

NEW YORK, March 21 - Paracel's future as a Celera Genomics subsidiary is unclear, people close to Celera say.

NEW YORK, March 21 - German functional-genomics company Xantos on Thursday said it has won an €803,000, or roughly $708,000, government grant.

NEW YORK, March 21 - Nanogen plans to launch 10 new analyte specific reagents in 2002, according to a company official.

SANTA CRUZ, Calif., March 21 - Researchers at the University of California, Santa Cruz have added a mouse genome assembly to their popular web-based browser that features the human genome assembly.

NEW YORK, March 21 - Exelixis on Wednesday said that increased corporate collaborations helped boost fourth-quarter revenue to $12.8 million from $7.1 million posted during the same time last year.

NEW YORK, March 21 - CombiMatrix may have its own stock if a plan floated by its parent company, Acacia Research, is approved.

NEW YORK, March 21 - The European Commission has spent €40 million, or $35 million, to launch a new genomics research initiative that will create an international mutant mouse-analysis consortium, fund a €13.7 milli

SAN FRANCISCO, March 20 - Picture a room the size of a railroad boxcar filled with lab glass, electronics, and robotics.

NEW YORK, March 20-Eric Eastman will be the first pres

NEW YORK, March 20-Genome Therapeutics said today that it had chosen a compound series to optimize as part of its anti-ulcer research and development partnership with AstraZeneca.

NEW YORK, March 20-MWG Biotech said today that its Italian subsidiary will be sequencing and annotating the complete genome of an 8 megabase bacterium for Aventis Bulk SpA, an Italian division of Aventis Pharma.


Science speaks with the University of Michigan's Jedidiah Carlson, who has tracked population genetic discussions at white nationalist sites.

Gene therapies could qualify for a faster US Food and Drug Administration approval process, according to Stat News.

NPR reports that the US House of Representatives has passed a bill to enable terminally ill patients access to experimental drugs.

In Genome Research this week: inversion variants mapped in human, non-human primate genomes; transcriptome profiling of maize, sorghum; and more.